Bruker Corporation

Equities

BRKR

US1167941087

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 10:50:51 2024-05-10 am EDT			5-day change	1st Jan Change
75.47 ^USD	-0.97%		+7.55%	+2.52%

May. 07	Bruker's NanoString Secures Patent Case Win in Germany	MT
May. 06	Bruker Corporation completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V.	CI

Bruker Corporation Appoints Falko Busse as an Executive Officer, Effective May 1, 2018

April 26, 2018 at 07:00 am EDT

Bruker Corporation announced the appointment of Dr. Falko Busse as an executive officer of the company, effective as of May 1, 2018. Dr. Busse joined Bruker BioSpin in 2015 as Executive Vice President of Research and Development. He assumed responsibility for BioSpin operations, marketing and strategy in early 2017, and was promoted to Deputy BioSpin Group president in October 2017.

Latest news about Bruker Corporation

Bruker's NanoString Secures Patent Case Win in Germany	May. 07	MT
Bruker Corporation completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V.	May. 05	CI
Bruker Shares Fall After Q1 Revenue Misses Consensus Views; Lifts Full-Year Guidance	May. 02	MT
Transcript : Bruker Corporation, Q1 2024 Earnings Call, May 02, 2024	May. 02
Earnings Flash (BRKR) BRUKER CORPORATION Posts Q1 Revenue $721.7M, vs. Street Est of $729M	May. 02	MT
Earnings Flash (BRKR) BRUKER CORPORATION Reports Q1 EPS $0.53, vs. Street Est of $0.46	May. 02	MT
Bruker Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
Bruker Corporation Revises Earnings Guidance for the Year 2024	May. 02	CI
Bruker Corporation completed the acquisition of ELITech Group SAS from Tecfin S.À R.L.	Apr. 29	CI
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference	Apr. 26	CI
Bruker Agrees Signs Asset Purchase Deal With NanoString Technologies	Apr. 22	MT
Bruker Corporation entered into an agreement to acquire Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $390 million.	Apr. 16	CI
Goldman Sachs Raises Price Target on Bruker to $74 From $66, Maintains Sell Rating	Apr. 10	MT
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies	Apr. 08	CI
Bruker Corporation Enters into Term Loan Agreement with Bank of America, N.A	Apr. 02	CI
Bruker Corporation Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO	Mar. 11	CI
Bruker Corporation completed the acquisition of Chemspeed Technologies AG.	Mar. 06	CI
Transcript : Bruker Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 09:50 AM	Mar. 04
UBS Raises Bruker Price Target to $102 From $94, Maintains Buy Rating	Mar. 01	MT
Transcript : Bruker Corporation Presents at Citi?s 2024 Unplugged Medtech and Life Sciences Access Day, Feb-29-2024 08:45 AM	Feb. 29
Bruker to Acquire ELITechGroup for About $943 Million in Cash	Feb. 28	MT
Bruker Corporation entered into an agreement to acquire ELITech Group SAS from Tecfin S.À R.L. for approximately ?870 million.	Feb. 27	CI
Bruker Insider Sold Shares Worth $1,276,073, According to a Recent SEC Filing	Feb. 26	MT
Bruker Keeps Quarterly Dividend at $0.05 Per Share, Payable March 15 to Shareholders of Record on March 1	Feb. 16	MT
Bruker Corporation Approves Payment of A Quarterly Cash Dividend, Payable on March 15, 2024	Feb. 16	CI

Chart Bruker Corporation

Duration

Period

More charts

Company Profile

Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. The Companyâs BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. It offers scanning transmission electron microscopes (STEM). It also offers advanced research Raman microscopy systems.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-22 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Bruker Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

76.21 USD

Average target price

85.7 USD

Spread / Average Target

+12.46%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BRUKER CORPORATION	+2.52%	11.08B
THERMO FISHER SCIENTIFIC	+11.24%	221B
DANAHER CORPORATION	+9.10%	186B
INTUITIVE SURGICAL, INC.	+14.61%	137B
BOSTON SCIENTIFIC CORPORATION	+28.37%	109B
SIEMENS HEALTHINEERS AG	0.00%	63.09B
EDWARDS LIFESCIENCES CORPORATION	+14.87%	52.68B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.86%	50.86B
AGILENT TECHNOLOGIES, INC.	+7.67%	42.53B
GE HEALTHCARE TECHNOLOGIES INC.	+7.15%	37.76B

Other Advanced Medical Equipment & Technology